Javier López‐Jiménez

3.2k total citations
60 papers, 729 citations indexed

About

Javier López‐Jiménez is a scholar working on Hematology, Oncology and Infectious Diseases. According to data from OpenAlex, Javier López‐Jiménez has authored 60 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Oncology and 14 papers in Infectious Diseases. Recurrent topics in Javier López‐Jiménez's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Javier López‐Jiménez is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Javier López‐Jiménez collaborates with scholars based in Spain, United States and Italy. Javier López‐Jiménez's co-authors include Fernando Martín‐Moro, Miguel Piris‐Villaespesa, Jesús Fortün, Pilar Herrera, J Odriozola, Juan Marquet, Javier Silvestre‐Rangil, Carlota García‐Hoz, Carlos Jiménez and Adolfo Sáez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Javier López‐Jiménez

57 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier López‐Jiménez Spain 15 234 231 213 135 131 60 729
Riad El Fakih Saudi Arabia 13 275 1.2× 218 0.9× 122 0.6× 98 0.7× 110 0.8× 76 672
Rishi S. Kotecha Australia 18 238 1.0× 235 1.0× 122 0.6× 108 0.8× 159 1.2× 72 880
Roni Tamari United States 18 601 2.6× 278 1.2× 135 0.6× 205 1.5× 161 1.2× 98 977
Birte Wistinghausen United States 11 266 1.1× 293 1.3× 172 0.8× 58 0.4× 54 0.4× 29 705
Adrienne de Labarthe France 11 636 2.7× 130 0.6× 166 0.8× 96 0.7× 163 1.2× 20 831
Hyun-Sook Chi South Korea 13 225 1.0× 101 0.4× 80 0.4× 68 0.5× 99 0.8× 33 503
Oren Pasvolsky Israel 14 337 1.4× 137 0.6× 68 0.3× 143 1.1× 111 0.8× 64 609
Hyery Kim South Korea 16 198 0.8× 152 0.7× 59 0.3× 104 0.8× 110 0.8× 100 665
Karima Yakouben France 19 459 2.0× 172 0.7× 54 0.3× 119 0.9× 90 0.7× 50 893
Aengus O’Marcaigh Ireland 19 344 1.5× 213 0.9× 76 0.4× 116 0.9× 276 2.1× 66 1.1k

Countries citing papers authored by Javier López‐Jiménez

Since Specialization
Citations

This map shows the geographic impact of Javier López‐Jiménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier López‐Jiménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier López‐Jiménez more than expected).

Fields of papers citing papers by Javier López‐Jiménez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier López‐Jiménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier López‐Jiménez. The network helps show where Javier López‐Jiménez may publish in the future.

Co-authorship network of co-authors of Javier López‐Jiménez

This figure shows the co-authorship network connecting the top 25 collaborators of Javier López‐Jiménez. A scholar is included among the top collaborators of Javier López‐Jiménez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier López‐Jiménez. Javier López‐Jiménez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sureda, Anna, Ramón García‐Sánz, Eva Domingo‐Doménech, et al.. (2025). Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study. Cancers. 17(7). 1137–1137.
3.
Martín‐Moro, Fernando, Javier López‐Jiménez, José A. García‐Marco, & José A. García-Vela. (2024). Comparative Review of the Current and Future Strategies to Evaluate Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma Diagnosis. Diagnostics. 14(6). 658–658. 2 indexed citations
4.
Fortün, Jesús, Pilar Martín‐Dávila, Alicia Gómez‐López, et al.. (2024). A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis. Journal of Fungi. 10(3). 191–191. 4 indexed citations
5.
Fortün, Jesús, Cruz Soriano, David Pestaña, et al.. (2023). Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection. Journal of Fungi. 9(2). 130–130. 6 indexed citations
6.
Rodríguez-Mora, Sara, Magdalena Corona, Elena Mateos, et al.. (2023). Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19. Cancers. 15(20). 5066–5066. 1 indexed citations
7.
Rodríguez-Mora, Sara, Javier García‐Pérez, Magdalena Corona, et al.. (2022). Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection. Journal of Clinical Medicine. 11(8). 2137–2137. 2 indexed citations
8.
Torres, Montserrat, Magdalena Corona, Sara Rodríguez-Mora, et al.. (2022). Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers. 14(22). 5537–5537. 1 indexed citations
9.
Rodríguez-Mora, Sara, Magdalena Corona, Montserrat Torres, et al.. (2022). Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19. Journal of Clinical Medicine. 11(10). 2803–2803. 5 indexed citations
10.
Perez‐Mies, Belén, Jesús Villarrubia, Sandra Chamorro, et al.. (2021). Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore. Journal of Clinical Pathology. 75(6). 383–389. 16 indexed citations
11.
Piris‐Villaespesa, Miguel, Alberto Álvarez‐Larrán, Adolfo Sáez, et al.. (2021). Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera. Scientific Reports. 11(1). 209–209. 5 indexed citations
12.
Alonso, Rafael, María‐Teresa Cedena, Sandy W. Wong, et al.. (2020). Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma. Blood Advances. 4(10). 2163–2171. 27 indexed citations
13.
García‐Gutiérrez, Valentín, et al.. (2020). Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19. Bone Marrow Transplantation. 56(1). 267–269. 14 indexed citations
14.
Alonso, Rafael, María‐Teresa Cedena, Adolfo Gómez‐Grande, et al.. (2019). Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma. American Journal of Hematology. 94(8). 853–861. 30 indexed citations
15.
Gallardo, David, Rocío Rodriguez, Ismael Buño, et al.. (2017). Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches. Biology of Blood and Marrow Transplantation. 23(12). 2042–2047. 4 indexed citations
16.
Papadopoulos, Kyriakos P., Javier López‐Jiménez, Scott E. Smith, et al.. (2016). A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma. Leukemia & lymphoma. 57(8). 1848–1855. 34 indexed citations
17.
Duarte, Rafael F., Javier López‐Jiménez, Oliver A. Cornely, et al.. (2014). Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia. Antimicrobial Agents and Chemotherapy. 58(10). 5758–5765. 81 indexed citations
18.
García‐Gutiérrez, Valentín, et al.. (2011). Impact of Second-Generation Tyrosine Kinase Inhibitors As Second Line Treatment for Patients with Chronic Myeloid Leukemia,. Blood. 118(21). 3780–3780. 12 indexed citations
19.
Escribano, Luís, et al.. (2004). Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis. Journal of Allergy and Clinical Immunology. 114(1). 28–33. 16 indexed citations
20.
López‐Jiménez, Javier, et al.. (2003). Coffin-Lowry syndrome: odontologic characteristics. Review of the literature and presentation of a clinical case.. PubMed. 8(1). 51–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026